Blue Eagle Lithium
High Times
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

For new investors: Please DD Silicon Valley biotech,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DDStocks Member Profile
Member Level 
Followed By 15
Posts 2,544
Boards Moderated 5
Alias Born 12/18/12
160x600 placeholder
Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics GlobeNewswire Inc. - 10/22/2018 5:30:00 AM
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists GlobeNewswire Inc. - 10/8/2018 5:30:00 AM
Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration GlobeNewswire Inc. - 9/24/2018 5:30:00 AM
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services GlobeNewswire Inc. - 9/10/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers GlobeNewswire Inc. - 8/27/2018 5:30:00 AM
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain GlobeNewswire Inc. - 8/13/2018 5:30:00 AM
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics GlobeNewswire Inc. - 7/30/2018 5:30:00 AM
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration GlobeNewswire Inc. - 7/16/2018 5:30:00 AM
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains GlobeNewswire Inc. - 7/2/2018 5:30:00 AM
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network GlobeNewswire Inc. - 6/18/2018 5:30:00 AM
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement GlobeNewswire Inc. - 5/30/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2018 1:55:34 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/22/2018 2:12:50 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/19/2018 6:37:10 PM
DDStocks Member Level  Tuesday, 12/05/17 06:21:44 PM
Re: None
Post # of 104252 

For new investors: Please DD Silicon Valley biotech, Arrayit Corporation (ARYC) this holiday weekend....Many new updates last week on Twitter @Arrayit $ARYC

Currently just under .01, rising steadily almost every day and it is so unbelievably undervalued......

Arrayit services team doubles manufacturing capacity to meet increasing demand for our proprietary microarray tech arrayit.com/index.html !!!

The more DD you do....the more information you will find that will make you shake your head in disbelief that ARYC is trading at this extremely low price

Arrayit completes strategic conference call with $183.9 billion pharmaceutical giant Novartis NYSE:NVS Cambridge MA https://www.novartis.com

One week sales:

Arrayit reports $41,000 microarray product sale to a top research laboratory studying coordinate gene expression arrayit.com/Products/produ…

Arrayit reports $38,000 microarray services sale to a top proteomics research laboratory arrayit.com/Services/servi…

Arrayit reports $69,000 micrroarray technology sale to a top biomedical research laboratory located northeastern USA arrayit.com/Products/produ…

Arrayit reports $28,000 microarray services sale to a leading research laboratory headquartered in the southwest USA arrayit.com/Services/servi…

Arrayit reports $228,000 microarray technology and services lead from top United States Department Agriculture USDA usda.gov

Arrayit reports $67,000 microarray services sale to a top USA-based research laboratory studying lymphocyte function arrayit.com/Services/servi…

Arrayit reports $36,000 microarray services sale to a top research laboratory in the USA arrayit.com/Services/servi…

Arrayit reports $47,700 microarray services sale to top research laboratory arrayit.com/Services/servi…

Arrayit reports $46,000 microarray instrument inquiry from leading Folkhälsan Institute of Genetics Helsinki Finland helsinki.fi/en

Arrayit reports $71,500 microarray technology sale to a top research laboratory focusing on gene expression analysis arrayit.com/Services/servi…


Arrayit reports $35,000 microarray services sale to a leading research laboratory specializing in complex pathways
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit new 3/23/2017 company newsletter features serum separation blood card tech for clinical microarray research
(link: http://arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html)
arrayit.com/Microarray_Dia…

Arrayit reports $100,000+ microarray services sale to a leading US-based research laboratory
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…

Arrayit reports partnership opportunity with $655MM healthcare manufacturing leader Quidel Nasdaq:QDEL San Diego CA
(link: http://www.quidel.com/spg)
quidel.com/spg

Arrayit Corporation provides $10MM funding proposal to top middle market merchant bank Aleutian Capital
http://www.
aleutiancapital.com

?pic.twitter.com/0FGHPyYkO9?

@Arrayit on Twitter

A list of Arrayit Corporation patents:

https://t.co/EMXlE743rz

Arrayit microarray platform used by customers at University Medicine Bethesda MD to publish cancer research advance

www.twitter.com/arrayit

WWW.Arrayit.com
Arrayit production team expands blood card manufacturing to 10,000 units per week to meet microarray research demand
http://
arrayit.com/Products/Prote
in_Microarrays/Blood_Card/blood_card.html

Arrayit anticipates significant participation in new congressional proposal for $4.8 billion 21st Century Cures Act
https://www.
genomeweb.com/policy-legisla
tion/congressional-committees-release-final-draft-21st-century-cures-act


Arrayit customers at Axo Science Lyon France use Arrayit microarray platform to ID bladder cancer prevention markers
http://
arrayit.com/Publications/b
ladder-cancer-prevention.pdf

Arrayit reports microarray technology sale to top nanotechnology healthcare leader Sonanutech Davis CA
http://
sonanutech.net

Arrayit reports microarray technology sale to world diagnostics leader Ventana Medical Sysytems Roche Tucson AZ
http://www.
ventana.com

Arrayit contact top Wells Fargo analyst Tim Evans explains revenue/earnings synergies in life science & diagnostics
http://
arrayit.com/Wells-Fargo-16
1114.pdf


Arrayit ships $35K proprietary microarray platform to leading European distributor Grupo Taper Mem Martins Portugal
http://www.
taper.es

Arrayit reports microarray technology sale to agricultural biotechnology leader Microgaia Biotech Murcia Spain
http://
microgaia.eu

Arrayit reports $100K microarray technology sale to world proteomics leader CDI Laboratories located in Baltimore MD
http://
cdi-lab.com

Arrayit featured in Global DNA Microarray Market Research Report 2016 with top molecular DX companies GE and Cepheid
http://www.
reportsnreports.com/reports/732130
-global-dna-microarray-market-research-report-2016.html


Arrayit designs custom microarray technology platform for top wellness testing company located in the European Union
http://
arrayit.com/Products/Micro
array_Platforms/microarray_platforms.html


Arrayit customers at the Korea Research Institute use the Arrayit microarray platform to publish biosensors advance
http://
pubs.acs.org/doi/abs/10.102
1/acs.analchem.6b02071


Arrayit confirms site visit business development meeting with advanced genomics leader Genomic Vision Bagneux France
http://www.
genomicvision.com

Arrayit SpotBot® Extreme Microarray Spotter newsletter receives 3,265 hits on life sciences tools segment strength
http://
arrayit.com/Products/Micro
arrayers/Microarray_Spotter/microarray_spotter.html


Arrayit reports $200,000 microarray platform inquiry from top life sciences leaders AH Diagnostics Aarhus Denmark
http://www.
ahdiagnostics.dk

Arrayit reports $34K microarray instrument sale to top European Union life sciences distributor European Biotech Network Dolembreux Belgium.

Arrayit equity research contact Tim Evans Wells Fargo illustrates 15-quarter strength of venture capital investing in biotechnology sector.



Report TOS


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist